210223-01-1

Basic information

• Product Name: tert-butyl 3-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate
• Synonyms: tert-butyl 3-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate
• CAS NO: 210223-01-1
• Molecular Formula: C15H27NO4
• Molecular Weight: 285.37918
• Mol File: 210223-01-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 3-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate(210223-01-1)
• EPA Substance Registry System: tert-butyl 3-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate(210223-01-1)

Safety Data

• Hazardous Substances Data: 210223-01-1(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 188883-61-6 (R)-3-Piperidin-3-yl-propionic acid ethyl ester 
• 91017-00-4 3-(piperidin-3-yl)propionic acid ethyl ester 
• 59607-99-7 ethyl (E)-3-(pyridin-3-yl)acrylate 
• 1008562-87-5 tert-butyl (3S)-3-formylpiperidine-1-carboxylate 
• 199174-24-8 tert-butyl (3S)-3-(hydroxymethyl)pyrrolidine-1-carboxylate 

Downstream Products

• 193628-06-7 (R)-3-{3-[4-Benzyloxy-2-(4-chloro-phenoxymethyl)-benzoimidazol-1-yl]-propyl}-piperidine-1-carboxylic acid tert-butyl ester 
• 210564-95-7 (R)-3-{3-[2-(4-Chloro-phenoxymethyl)-4-hydroxy-benzoimidazol-1-yl]-propyl}-piperidine-1-carboxylic acid tert-butyl ester 
• 210565-05-2 (S,R)-1-{3(S)-[N-(tert-butyloxycarbonyl)-3-piperidinyl]propyl}-2-[(4-chlorophenoxy)methyl]-4-({3(R)-[N-(tert-butyloxycarbonyl)-3-piperidinyl]propyl}oxy)benzimidazole 
• 193627-94-0 (R,R)-1-{3(R)-[N-(tert-butyloxycarbonyl)-3-piperidinyl]propyl}-2-[(4-chlorophenoxy)methyl]-4-({3(R)-[N-(tert-butyloxycarbonyl)-3-piperidinyl]propyl}oxy)benzimidazole 
• 210565-12-1 (R,S)-1-{3(R)-[N-(tert-butyloxycarbonyl)-3-piperidinyl]propyl}-2-[(4-chlorophenoxy)methyl]-4-({3(S)-[N-(tert-butyloxycarbonyl)-3-piperidinyl]propyl}oxy)benzimidazole 

Relevant articles and documents

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.

Synthesis and evaluation of a series of novel 2-[(4- chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists

A series of novel benzimidazoles (BI) derived from the indole 2 was synthesized and evaluated as selective neuropeptide Y (NPY) Y1 receptor antagonists with the aim of developing antiobesity drugs. In our SAR approach, the (4-chlorophenoxy)methyl group at